Trends in prevalence of gestational diabetes and perinatal outcomes in Catalonia, Spain, 2006 to 2015: the Diagestcat Study

Gortazar, Lucía; Roux, Juana A. Flores‐Le; Benaiges, David; Sarsanedas, Eugènia; Payà, Antoni; Mañé, Laura; Pedro‐Botet, Juan; Goday, Alberto

doi:10.1002/dmrr.3151

Cited by 39 publications

(44 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Urinary tract infection (n = 3; 3.4%), hypoglycemia (n = 2; 2.27%), polyhydramnios (n = 2; 2.27%), vaginitis (n = 4; 4.54%), pre-eclampsia (n = 4; 4.54%) and chronic fetal distress with IUGR (n = 2; 2.27%) were the secondary outcomes identified during prenatal followups. These findings are compatible with data available in the medical literature [28][29][30][31][32]34,35].…”

Section: Discussionsupporting

confidence: 92%

“…Diabetic pregnant women presented the following primary outcomes: fetal and neonatal mortality (1.8%), macrosomia (6.81%), prematurity (16.6%) and hospitalization in neonatal ICU (9 %). All these findings presented lower rates than the ones reported in many other services [32][33][34][35]. There was an association between diabetes and prematurity and between diabetes and hospitalization in neonatal ICU (p < 0.05).…”

Section: Discussionmentioning

confidence: 56%

See 1 more Smart Citation

Gestational and Previous Diabetes in Pregnancy: Perinatal Results

Ja¹,

Gqa²,

Pm³

et al. 2020

Asp Biomed Clin Case Rep

View full text Add to dashboard Cite

Objective: Evaluating the association between gestational diabetes and fetal/maternal complications such as poor obstetric outcomes. Methods: Historical cohort comprising patients from the High-Risk Service of Federal University of Juiz de Fora (UFJF,) who were diagnosed with diabetes (exposed), as well as patients from the Low-Risk Service of UFJF (non-exposed). Data generated through anamnesis, physical examination and medical conduct, as well as data of newborns such as fetal weight, ICU admission and fetal/neonatal death), were collected and stored in the Epi Info software (version 6.0); p < 0.05. Results: 176 patients treated in the aforementioned services, 108 diabetic, and 68 non-diabetics, were investigated in the current study. In total, 92 (52.2%) of them were diagnosed with Gestational Diabetes Mellitus (GDM); 6 had DM type 1 (3.4%) and 10 had DM type 2 (5.6%). Therefore, 68 patients (38.6%) presented normal glucose metabolism. The mean age of the patients was 30.27 ± 6.77 years, the mean number of births was 1.06 ± 1.20. Macrosomia was diagnosed in 6.81% (n = 6) of the cases; it was associated with maternal glycemia (p < 0.05). D- and F-class pregnant women, who had been previously diagnosed with diabetes, presented lower fetal weight than other pregnant women (p = 0.03). Treatment was based on diet, insulin or metformin, whenever necessary. Fasting glycemia levels decreased throughout the gestational trimesters. Eighteen (10.2%) preterm fetuses were identified; 12 were born from diabetic mothers and 6 were born from non-diabetic ones (p = 0.01; X2 = 10.51). All infants hospitalized in the neonatal ICU (n = 10) were born from diabetic mothers; their mean gestational age was 36.28 + 2.9 weeks, whereas the mean gestational age of infants who were not hospitalized in the ICU was 38.31 ± 1.5 (p = 0.005; T = 12.58). Cesarean section was the most common way of delivery adopted for diabetic pregnant women (p = 0.04). Conclusion: Based on the results, gestational diabetes (GDM) is a predisposing factor to fetal macrosomia, prematurity, and hospitalization in neonatal ICUs. Pregnant women subjected to proper glycemic control in the current study presented lower complication rates in comparison to other studies in the literature.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 56%

Gestational and Previous Diabetes in Pregnancy: Perinatal Results

Ja¹,

Gqa²,

Pm³

et al. 2020

Asp Biomed Clin Case Rep

View full text Add to dashboard Cite

show abstract

“…Lavery et al reported about 5.5% increase in GDM prevalence in the USA over a 20-year period from 1990 to 2010 [3]. A study in Spain examining the trend of GDM prevalence showed an increase of 4.8% over a period of 9 years from 2006 to 2015 [4]. According to the International Diabetes Federation, South East Asia had the highest prevalence of GDM with 26.6% followed by Middle East/North Africa (18%), Europe (14%) and Africa (9.5%) [2].…”

Section: Prevalence Worldwide and The Trends Over The Past Decadementioning

confidence: 98%

The Role of Dietary Carbohydrates in Gestational Diabetes

et al. 2020

View full text Add to dashboard Cite

Gestational diabetes (GDM) is hyperglycemia that is recognized for the first time during pregnancy. GDM is associated with a wide range of short- and long-term adverse health consequences for both mother and offspring. It is a complex disease with a multifactorial etiology, with disturbances in glucose, lipid, inflammation and gut microbiota. Consequently, its management is complex, requiring patients to self-manage their diet, lifestyle and self-care behaviors in combination with use of insulin. In addition to nutritional recommendations for all pregnant women, special attention to dietary carbohydrate (CHO) amount and type on glucose levels is especially important in GDM. Dietary CHO are diverse, ranging from simple sugars to longer-chain oligo- and poly- saccharides which have diverse effects on blood glucose, microbial fermentation and bowel function. Studies have established that dietary CHO amount and type can impact maternal glucose and nutritional recommendations advise women with GDM to limit total intake or choose complex and low glycemic CHO. However, robust maternal and infant benefits are not consistently shown. Novel approaches which help women with GDM adhere to dietary recommendations such as diabetes-specific meal replacements (which provide a defined and complete nutritional composition with slowly-digested CHO) and continuous glucose monitors (which provide unlimited monitoring of maternal glycemic fluctuations) have shown benefits on both maternal and neonatal outcomes. Continued research is needed to understand and develop tools to facilitate patient adherence to treatment goals, individualize interventions and improve outcomes.

show abstract

“…У третьому мета-аналізі (Behboudi-Gandevani С, 2019) [4], що включав 51 популяційне дослідження (5439476 вагітних жінок), загальна поширеність ГЦД, незалежно від референтних значень скринінгу, становила 4,4% з найвищою частотою в Східній Азії та найменшою -в Австралії (відповідно, 11,4% і 3,6%). За даними окремих наукових джерел поширеність цукрового діабету (ЦД) у Франції становить 7,24% [5], в Іспанії -4,8% [6], у США -15% [7] та в Австралії -13% [8].…”

Section: вступunclassified

Frequency and Risks of Adverse Outcomes Associated With Gestational Diabetes Mellitus in Neonates

Klymchuk¹

2019

Act. Probl. of the Modern Med.

View full text Add to dashboard Cite

Gestational diabetes mellitus (GDM) is one of the most common endocrinopathies during pregnancy. The issue on the prevalence of its adverse outcomes depending on the time of diabetes onset – before or during pregnancy – is still remaining unclear. The aim of this study was to determine the prevalence and risk of adverse outcomes associated with GDM in neonates in Poltava region. Materials and methods. We conducted a retrospective study that included 10.025 infants born to primigravidae under 28 weeks. Group I included infants (n = 35) who were born to mothers with GDM, and group II covered infants (n = 82) who were born to mothers with pre-gestational diabetes mellitus (PGDM). The control group included 9908 infants who were born to mothers without diabetes. Results. The risks of neonatal respiratory distress were significantly higher in neonates born to women with PGDM and GDM than in women without diabetes (RR 59.6 (95% CI 39.9-88.9) and RR 81.7 (95% CI 38.1- 175), whereas the risk of asphyxia was higher only in women with GDM (RR 16.4 (95% CI 6.5-41.4). Among the mothers with PGDM and GDM, no significant differences were observed in the number of infants with macrosomia (51.4% and 61.0%), hypoglycemia (37.1% and 31.7%), hospitalization in the intensive care unit (31.4% and 48.8%) and mechanical ventilation (20.0% and 23.2%). Conclusion. Diabetes mellitus is associated with an increased risk of developing maternal and neonatal adverse outcomes. The incidence of preeclampsia, premature birth, neonatal respiratory distress, macrosomia, and the use of mechanical ventilation in infants are the same in mothers with gestational and pre-gestational diabetes mellitus.

show abstract

Trends in prevalence of gestational diabetes and perinatal outcomes in Catalonia, Spain, 2006 to 2015: the Diagestcat Study

Cited by 39 publications

References 37 publications

Gestational and Previous Diabetes in Pregnancy: Perinatal Results

Gestational and Previous Diabetes in Pregnancy: Perinatal Results

The Role of Dietary Carbohydrates in Gestational Diabetes

Frequency and Risks of Adverse Outcomes Associated With Gestational Diabetes Mellitus in Neonates

Contact Info

Product

Resources

About